Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and a recruitment status label 'No longer looking for participants', along with an updated site revision tag 'Revision: v3.6.0'. The removal of the 'Intervention / Treatment' label and the older 'Revision: v3.5.5' entry indicates a UI cleanup and version update.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated site build.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3, indicating a software update behind the page. No visible content changes to the study details are indicated.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision was bumped from v3.5.2 to v3.5.3, indicating a new version of the page content has been published. This reflects maintenance or minor behind-the-scenes updates to the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page's revision badge was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.